O'Hara HA, Silver JS, Hunter CA: The immunology of IL-27. Advances in Immunology. Adv Immunol. 2012, 115: 1-44.
Article
Google Scholar
Chae SC, Li CS, Kim KM, Yang JY, Zhang Q, Lee YC, Yang YS, Chung HT: Identification of polymorphisms in human interleukin-27 and their association with asthma in a Korean population. J Hum Genet. 2007, 52: 355-361. 10.1007/s10038-007-0123-8.
Article
CAS
PubMed
Google Scholar
Li CS, Zhang Q, Lee KJ, Cho SW, Lee KM, Hahm KB, Choi SC, Yun KJ, Chung HT, Chae SC: Interleukin-27 polymorphisms are associated with inflammatory bowel diseases in a Korean population. J Gastroenterol Hepatol. 2009, 1692-1696. 24
Huang ZQ, Wang JL, Pan GG, Wei YS: Association of single nucleotide polymorphisms in IL-12 and IL-27 genes with colorectal cancer risk. Clin Biochem. 2012, 54-59. 45
Robinson CM, Nau GJ: Interleukin-12 and interleukin-27 regulate macrophage control of Mycobacterium tuberculosis. J Infect Dis. 2008, 359-366. 198
Peng Q, Qin X, He Y, Chen Z, Deng Y, Li T, Xie L, Zhao J, Li S: Association of IL27 gene polymorphisms and HBV-related hepatocellular carcinoma risk in a Chinese population. Infect Genet Evol. 2013, 1-4. 16
Imamichi T, Yang J, Huang DW, Brann TW, Fullmer BA, Adelsberger JW, Lempicki RA, Baseler MW, Lane HC: IL-27, a novel anti-HIV cytokine, activates multiple interferon-inducible genes in macrophages. AIDS. 2008, 39-45. 22
Fakruddin JM, Lempicki RA, Gorelick RJ, Yang J, Adelsberger JW, Garcia-Pineres AJ, Pinto LA, Lane HC, Imamichi T: Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27. Blood. 2007, 109: 1841-1849. 10.1182/blood-2006-02-001578.
Article
PubMed Central
PubMed
Google Scholar
Liu L, Cao Z, Chen J, Li R, Cao Y, Zhu C, Wu K, Wu J, Liu F, Zhu Y: Influenza A virus induces interleukin-27 through cyclooxygenase-2 and protein kinase A signaling. J Biol Chem. 2012, 287: 11899-11910. 10.1074/jbc.M111.308064.
Article
PubMed Central
CAS
PubMed
Google Scholar
Frank AC, Zhang X, Katsounas A, Bharucha P J, Kottilil S, Imamichi T: Interleukin-27, an anti-HIV-1 cytokine, inhibits replication of Hepatitis C virus. Journal of Interferon & Cytokine Research. 2010, 30: 427-431. 10.1089/jir.2009.0093.
Article
CAS
Google Scholar
Wright M, Goldin R, Fabre A, Lloyd J, Thomas H, Trepo C, Pradat P, Thursz M, HENCORE collaboration: Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study. Gut. 2003, 52: 574-579. 10.1136/gut.52.4.574.
Article
PubMed Central
CAS
PubMed
Google Scholar
McCaughan GW, George J: Fibrosis progression in chronic hepatitis C virus infection. Gut. 2004, 53: 318-321. 10.1136/gut.2003.026393.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hutchison SJ, Bird SM, Goldberg DJ: Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. Clin Gastroenterol Hepatol. 2005, 3: 1150-1159. 10.1016/S1542-3565(05)00407-6.
Article
Google Scholar
Minola E, Prati D, Suter F, Maggiolo F, Caprioli F, Sonzogni A, Fraquelli M, Paggi S, Conte D: Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Blood. 2002, 99: 4588-4591. 10.1182/blood-2001-12-0192.
Article
CAS
PubMed
Google Scholar
Castillo I, Rodríquez-Iñigo E, López-Alcorocho JM, Bartolomé J, Pardo M, Carreño V: Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection. J Med Virol. 2007, 236-241. 79
Nucara S, Caroleo B, Guadagnino V, Perrotti N, Trapasso F, Natural history and clinical response: it's the virus, stupid, or is it the host?. BMC Infect Dis. 2012, 12 (Suppl 2): S6-10.1186/1471-2334-12-S2-S6.
Article
PubMed Central
PubMed
Google Scholar
Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB: Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009, 461: 399-401. 10.1038/nature08309.
Article
CAS
PubMed
Google Scholar
Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, Ito Y, Mita E, Tanaka E, Mochida S, Murawaki Y, Honda M, Sakai A, Hiasa Y, Nishiguchi S, Koike A, Sakaida I, Imamura M, Ito K, Yano K, Masaki N, Sugauchi F, Izumi N, Tokunaga K, Mizokami M: Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 2009, 1105-1109. 41
Kawaoka T, Hayes CN, Ohishi W, Ochi H, Maekawa T, Abe H, Tsuge M, Mitsui F, Hiraga N, Imamura M, Takahashi S, Kubo M, Tsunoda T, Nakamura Y, Kumada H, Chayama K: Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b. J Hepatol. 2011, 408-414. 54
Imran M, Manzoor S, Ashraf J, Khalid M, Tariq M, Khaliq HM, Azam S: Role of viral and host factors in interferon based therapy of hepatitis C virus infection. Virol J. 2013, 10: 299-10.1186/1743-422X-10-299.
Article
PubMed Central
PubMed
Google Scholar
Cordoba-Rodriquez R, Frucht DM: IL-23 and IL-27: new members of the growing family of IL-12-related cytokines with important implications for therapeutics. Expert Opin Biol Ther. 2003, 715-723. 3